Cargando…
‘Mix and Match’ vaccination: Is dengue next?
The severity of the COVID-19 pandemic and the development of multiple SARS-CoV-2 vaccines expedited vaccine ‘mix and match’ trials in humans and demonstrated the benefits of mixing vaccines that vary in formulation, strength, and immunogenicity. Heterologous sequential vaccination may be an effectiv...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526515/ https://www.ncbi.nlm.nih.gov/pubmed/36195473 http://dx.doi.org/10.1016/j.vaccine.2022.09.007 |